Adropin as an indicator of T2DM and its complications
Type 2 diabetes mellitus (T2DM) is one of metabolic diseases with the major inducer of obesity. Due to the change in lifestyle and dietary structure, more and more people are being suffered from T2DM. Therefore, the prevention and treatment of T2DM and its complications has become an urgent problem...
Saved in:
Main Authors: | Hu Zhang, Ning Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Tsinghua University Press
2022-11-01
|
Series: | Food Science and Human Wellness |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2213453022000854 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum adropin levels as a potential biomarker for predicting diabetic kidney disease progression
by: I-Wen Chen, et al.
Published: (2025-02-01) -
Predictive biomarkers for cardiometabolic risk in postmenopausal women: insights into visfatin, adropin, and adiponectin
by: Anna Maria Cybulska, et al.
Published: (2025-02-01) -
Adropin: a key player in immune cell homeostasis and regulation of inflammation in several diseases
by: Junmin Wang, et al.
Published: (2025-01-01) -
Association between Mediterranean diet and metabolic health status among adults was not mediated through serum adropin levels
by: Maryam Shafiei, et al.
Published: (2025-01-01) -
The Correlation of Serum Adropin with Cardiovascular Risk Factors in the Experimental Rat Model of Chronic Kidney Disease and Its Implication in the Ameliorative Effect of Angiotensin-Converting Enzyme Inhibitors
by: Samaa Salah Abd-El-Fatah, et al.
Published: (2024-12-01)